Caliber Imaging & Diagnostics, Inc.
Caliber Imaging & Diagnostics, Inc.
Your view on LCDX
Overview
What the company does, where it operates, and who runs it.
About Caliber Imaging & Diagnostics, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- L. Michael Hone
- Headquarters
- 100 Burtt Road, Andover, MA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- L. Michael Hone
- Headquarters
- 100 Burtt Road, Andover, MA, US
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States.
The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging.
It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system.
The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Caliber Imaging & Diagnostics, Inc., and the rating behind it. LCDX last traded at $0.0006; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Caliber Imaging & Diagnostics, Inc.. Starting points for Caliber Imaging & Diagnostics, Inc.: EPS -$0.65, beta 0.17 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Caliber Imaging & Diagnostics, Inc.. Caliber Imaging & Diagnostics, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Caliber Imaging & Diagnostics, Inc.. Trailing twelve-month EPS for Caliber Imaging & Diagnostics, Inc. stands at -$0.65. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Caliber Imaging & Diagnostics, Inc.. Caliber Imaging & Diagnostics, Inc. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Caliber Imaging & Diagnostics, Inc. valued side by side against its closest peers. Caliber Imaging & Diagnostics, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Caliber Imaging & Diagnostics, Inc., and how their positions are changing. At a $5,104 market value, institutional positions materially move Caliber Imaging & Diagnostics, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Caliber Imaging & Diagnostics, Inc. executives and directors. Shares of Caliber Imaging & Diagnostics, Inc. have traded between $0.0001 and $0.0006 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Caliber Imaging & Diagnostics, Inc.. Caliber Imaging & Diagnostics, Inc. is a $5,104 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Caliber Imaging & Diagnostics, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Caliber Imaging & Diagnostics, Inc.. Coverage tracks Caliber Imaging & Diagnostics, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.